Non-vitamin-Koral anticoagulants and laboratory testing: Now and in the future: Views from a workshop at the European Medicines Agency (EMA)

Tomas Salmonson, Jean Michel Dogne, Heidi Janssen, Juan Garcia Burgos, Paul Blake

Résultats de recherche: Contribution à un journal/une revueArticle de revueRevue par des pairs

Résumé

In contrast to Vitamin K antagonists, no routine coagulation monitoring is required in patients taking non-vitamin-K oral anticoagulants (NOACs). However, dosing must take into account factors such as patient age, renal function, and accompanying haemorrhagic risk. There has been considerable debate about when laboratory measurement might be appropriate and which tests should be used. A workshop at the European Medicines Agency recently discussed the evidence about laboratory measurement from formal studies, clinical experience, and the multiple perspectives on NOAC treatment, and considered how our knowledge might be further enhanced.

langue originaleAnglais
Pages (de - à)42-47
Nombre de pages6
journalEuropean Heart Journal - Cardiovascular Pharmacotherapy
Volume3
Numéro de publication1
Les DOIs
Etat de la publicationPublié - 1 janv. 2017

Empreinte digitale Examiner les sujets de recherche de « Non-vitamin-Koral anticoagulants and laboratory testing: Now and in the future: Views from a workshop at the European Medicines Agency (EMA) ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation